| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2012-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2478dcc87ee2db0fbc960d3455eceae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c22fb0da882b9ef3028f0ce6dce5014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b6d11b8c81a3b22f1b38f084efaaf92 |
| publicationDate |
2014-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2013013059-A |
| titleOfInvention |
METHOD FOR THE TREATMENT OF SOLID MALIGNITIES THAT INCLUDE ADVANCED OR METASTASIC SOLID MALIGNITIES. |
| abstract |
The present invention relates to the use of Volasertib or a salt or its hydrate to treat patients suffering from solid malignancies that include advanced or metastatic solid malignancies comprising a high frequency administration of Volasertib according to a specific dosing schedule. |
| priorityDate |
2011-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |